<?xml version="1.0" encoding="UTF-8"?>
<ClinicalUseDefinition xmlns="http://hl7.org/fhir">
    <id value="CUD-Norway-2"/>
    <meta>
        <profile value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/ClinicalUseDefinition-undesirableEffect-uv-epi"/>
        <profile value="https://gravitatehealth.eu/fhir/nordic-epi-ig/StructureDefinition/Nordic-ePI-ClinicalUseDefinition-UndesirableEffect"/>
    </meta>
    <type value="undesirable-effect"/>
    <subject>
        <reference value="MedicinalProductDefinition/MPD-Norway-1"/>
    </subject>
    <undesirableEffect>
        <symptomConditionEffect>
            <concept>
                <coding>
                    <system value="http://terminology.hl7.org/CodeSystem/mdr"/>
                    <code value="10020993"/>
                    <display value="Hypoglycaemia"/>
                </coding>
            </concept>
        </symptomConditionEffect>
        <frequencyOfOccurrence>
            <coding>
                <system value="https://gravitatehealth.eu/meddra/frequency"/>
                <code value="001"/>
                <display value="svÃ¦rt vanlige"/>
            </coding>
        </frequencyOfOccurrence>
    </undesirableEffect>
</ClinicalUseDefinition>
